Merck & Co., Inc. is 80.8x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($294.13 B vs $3.64 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ACAD | MRK |
|---|---|---|
| Market cap | $3.64 B | $294.13 B |
| US-listed rank | #1651 | #44 |
| Revenue (latest FY) | $1.07B | $65.01B |
| Net income (latest FY) | $391.00M | $18.25B |
| Net margin | 36.5% | 28.1% |
| P/E (trailing FY) | 9.3 | 16.1 |
| SEC filings | 1,357 | 996 |
Merck & Co., Inc. is 80.8x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($294.13 B vs $3.64 B).
In their latest fiscal years, ACADIA PHARMACEUTICALS INC reported $1.07B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: ACADIA PHARMACEUTICALS INC and Merck & Co., Inc., or browse the full rankings.